You are here: Industry Insights > antibodies

News List

AbCellera Announces Secondary Private Sale of 11.9 Million Common Shares firstwordpharma
June 11, 2021
AbCellera (Nasdaq: ABCL) today announced that certain entities owned and/or controlled, directly or indirectly, by Carl Hansen, Ph.D., Cofounder, Chief Executive Officer, and President of AbCellera
Arcus Biosciences and WuXi Biologics expand deal for antibodies development pharmaceutical-technology
December 11, 2020
Biopharmaceutical company Arcus Biosciences has expanded its existing strategic relationship with Chinese company WuXi Biologics to discover anti-CD39 antibodies using the latter’s proprietary technology.
Research Antibodies and Reagents Market Worth $6.32 billion by 2027 prnewswire
November 19, 2020
Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research
Hybrid purifier removes host cell proteins during mAb bioprocessing, study shows europeanpharmaceuticalreview
November 17, 2020
Researchers have shown that a hybrid purifier can remove host cell proteins during the downstream processing of monoclonal antibodies.
Pre-existing coronavirus antibodies could help protect children against new pandemic strain worldpharmanews
November 10, 2020
Researchers at the Francis Crick Institute and University College London have found that some antibodies, created by the immune system during infection with common cold coronaviruses, can also target SARS-CoV-2 and may confer a degree of protection ...
Pre-existing antibodies may protect some people against COVID-19: Study expresspharma
November 10, 2020
Researchers found that some people, notably children, have antibodies reactive to the novel coronavirus SARS-CoV-2 in their blood, despite not ever having being infected with the virus.
Scientists develop COVID-19 vaccine candidate that generates very high neutralising antibodies expresspharma
November 06, 2020
The study finds that the nanoparticle vaccine generates ten times more protective antibodies in mice, even at a six-fold lower vaccine dose, and also shows a strong B-cell immune response after administration.
The Native Antigen Company Launches Range of SARS-CoV-2 Specific Antibodies americanpharmaceuticalreview
October 14, 2020
The Native Antigen Company has announced the introduction of ten new monoclonal antibodies recognizing SARS-CoV-2, the causative agent of COVID-19.
Seismic Bio partners with Twist Bioscience for discovery and optimisation of antibodies pharmaceutical-business-review
August 07, 2020
Twist Bioscience Corporation and Seismic Bio announced a partnership for the discovery and optimization of antibodies to high-value immuno-oncology targets.
Researchers say newly identified antibodies can neutralise SARS-CoV-2 pharmaceutical-technology
July 24, 2020
Researchers at Columbia University Irving Medical Center in the US have identified neutralising antibodies, isolated from Covid-19 patients, against the SARS-CoV-2 virus.

Previous page 1 2 3 4 5 6 Next page